Lilly’s stock rallies as sales of GLP-1 drugs nearly double

Chronological Source Flow
Back

AI Fusion Summary

Eli Lilly's stock rallied as GLP‑1 drug sales nearly doubled, with Mounjaro and Zepbound exceeding expectations and investors responded positively, as the company projects continued momentum. The company raised its annual profit forecast, citing GLP‑1 growth.
#LILLY #GLP_1 #MOUNJARO #ZEPBOUND #STOCK_RALLY #PROFIT_FORECAST
30/04 13:58 marketwatch.com
5 Πηγές

Lilly’s stock rallies as sales of GLP-1 drugs nearly double

POLITICS
30/04 14:01 investing.com

Eli Lilly raises annual profit forecast as GLP-1 drugs fuel growth

30/04 14:18 investing.com

Cardinal Health lifts annual profit forecast on strong demand for specialty drugs

POLITICS
30/04 14:53 yahoo.com

L3Harris lifts 2026 profit forecast on strong weapons demand

POLITICS
30/04 14:54 investing.com

L3Harris lifts 2026 profit forecast on strong weapons demand

POLITICS
Comments
Loading...
0